For many people who experience psoriasis, one of the biggest challenges is navigating the space between immediate care for early flare-ups and ongoing support for a healthy skin barrier, and Relab is launching to deliver skincare solutions that fill the gap. When it comes to supporting the skin and managing symptoms, a simpler routine is better, and Relab's debut lineup introduces three products: Barrier Restore Body Cream, Barrier Restore Face Cream, and Active Rescue Psoriasis Cream—the last of which is the star, featuring a patent-pending multifunctional protein designed to target inflammation earlier than current psoriasis treatments.
This new venture comes from Eric Cowles, former president of Dr. Dennis Gross Skincare and general manager at L’Oréal for Decléor, Carita and SkinCeuticals, and Ellie Schmidt, who was behind product development, formulation science and ingredient innovation at Murad, Moon Juice and Flamingo Estate.
What's Driving This Trend
- Biotech-backed Skincare
- Advanced proteins and formulation science are reshaping topical care by bringing pharmaceutical-style precision into everyday skincare routines.
- Flare-up Prevention
- Earlier intervention for inflammatory skin symptoms creates space for products that bridge acute relief and long-term condition management.
- Barrier-first Routines
- Simplified regimens centered on skin barrier repair reflect growing demand for multifunctional products that reduce complexity for chronic-skin consumers.
Who This Affects Most
- Dermatology
- Clinical skin care is expanding beyond prescription treatment as biotech-enabled consumer products support ongoing management between physician visits.
- Beauty and Personal Care
- Prestige skincare brands are gaining room to differentiate through science-led formulas designed for sensitive, reactive, and condition-specific needs.
- Biotechnology
- Patent-pending ingredient platforms are opening new commercial pathways for bioactive proteins within consumer health and beauty applications.
